№ lp_2_3_38422
Detailed patient characteristics, genomic breakpoints, assay parameters, and MRD quantification results are compiled from clinical samples and experimental analyses in this supplemental source.
Year: 2000–2022
Study Type: Clinical research
Patient Population: ABL-class leukemia patients
Sample Type: Bone marrow and blood DNA
Assay Methods: RNA sequencing, targeted locus amplification (TLA), genomic capture high throughput sequencing (gc-HTS), Fusion Detection by Gene Enrichment (FUDGE), long-range PCR, Sanger sequencing
Quantitative Assay: MRD Q-PCR based on genomic breakpoints and IG/TR targets
Institution: Princess Máxima Centrum, Netherlands; USEQ sequencing facility, Utrecht, Netherlands; Macrogen Europe
Ethics: Written informed consent obtained according to the Declaration of Helsinki
Data Tables: Supplemental Digital Tables 1–3
Figures: Supplemental Digital Figures 1–2
Reference Protocols: EuroMRD guidelines
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.